The atherogenic dyslipidemia ratio [log(TG)/HDL-C] is associated with residual vascular risk, beta-cell function loss and microangiopathy in type 2 diabetes females

BACKGROUND: Atherogenic dyslipidemia (AD), defined as low HDL-C plus elevated triglycerides (TG), comorbid to T2DM, increases cardiometabolic risk for CAD even when LDL-C is at target. In T2DM males, AD was shown to correlate with β-cell function loss, yet it is not established whether this applies...

Descripción completa

Detalles Bibliográficos
Autores principales: Hermans, Michel P, Ahn, Sylvie A, Rousseau, Michel F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539971/
https://www.ncbi.nlm.nih.gov/pubmed/23046637
http://dx.doi.org/10.1186/1476-511X-11-132

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3539971/
https://www.ncbi.nlm.nih.gov/pubmed/23046637
http://dx.doi.org/10.1186/1476-511X-11-132

Ejemplares similares